Shares of Novavax jumped after the biotech company said its new COVID vaccine generated a broad immune response against the now-dominant Eris variant and another fast-spreading strain of the virus.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
